Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.

Abstract

Aims/IntroductionUrinary kidney injury molecule‐1 (KIM‐1) has been associated with proximal tubular damage in human and animal studies. Although it has been recognized as a biomarker of acute kidney injury and chronic kidney disease, its significance in the serum remains unclear. Therefore, we examined the relationship of serum and urinary KIM‐1 levels with renal parameters in patients with type 2 diabetes.Materials and MethodsSerum and urinary KIM‐1 levels, together with urinary liver‐type fatty acid‐binding protein, were measured in 602 patients with type 2 diabetes and an estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2. These were then compared with the urinary albumin‐to‐creatinine ratio and eGFR.ResultsThe serum and urinary KIM‐1 levels were significantly different among the three (eGFR ≥60, 45–59, <45 mL/min/1.73 m2) groups. These levels were positively associated with the albumin‐to‐creatinine ratio and negatively associated with eGFR. In a multivariate logistic model, both serum and urinary KIM‐1 were associated with an increased albumin‐to‐creatinine ratio (>30 mg/g Cr), but only the serum KIM‐1 was associated with a lower eGFR (<60 mL/min/1.73 m2), after adjustment for covariates.ConclusionsRenal parameters appear to be strongly associated with serum KIM‐1, and not urinary KIM‐1, in patients with type 2 diabetes and an eGFR ≥30 mL/min/1.73 m2.